2023
DOI: 10.1016/j.expneurol.2023.114353
|View full text |Cite
|
Sign up to set email alerts
|

Critical points for optimizing long-term culture and neural differentiation capacity of rodent and human neural stem cells to facilitate translation into clinical settings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 207 publications
1
2
0
Order By: Relevance
“…However, it is known that cell culture protocols are not strictly standardized, which may lead to many still poorly investigated differences. These have been recently reported by our group [ 1 ] and others [ 16 ].…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…However, it is known that cell culture protocols are not strictly standardized, which may lead to many still poorly investigated differences. These have been recently reported by our group [ 1 ] and others [ 16 ].…”
Section: Discussionsupporting
confidence: 83%
“…The growth of various types of cells is an obligatory part of the in vitro modeling of any neurological disease. Cell culture techniques frequently incorporate various supplements, as is known, and it has been demonstrated by our group that they can drastically alter cells’ phenotype [ 1 ]. Moreover, for some supplements, it has been shown that they can have protective effects.…”
Section: Introductionmentioning
confidence: 99%
“…The application of ESCs or autologous stem cells for cell therapy is compromised for both ethical and practical reasons. However, the discovery of a method to obtain, from adult somatic cells, patient-specific iPSCs from which NSC can then be obtained and maintained [ 9 ] opens the possibility for personalized NSC or trophic-factor therapies [ 10 ]. The use of differentiated/somatic cells is also possible, as reported by Ma and colleagues in their clinical trial [ 8 ].…”
Section: Introductionmentioning
confidence: 99%